Home
About
FAQ
History (16)
Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy.
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma.
PCI is Not Predictive of Survival After Complete CRS/HIPEC in Peritoneal Dissemination from High-Grade Appendiceal Primaries.
Race and recurrence in women who undergo neoadjuvant chemotherapy for breast cancer.
Peritoneal carcinomatosis: what can we do about it?
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Peritoneal carcinomatosis: what can we do about it?
Shen P, Levine EA, Loggie BW. Peritoneal carcinomatosis: what can we do about it? J Clin Oncol. 2004 Jan 01; 22(1):202; author reply 203.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Carcinoma
Combined Modality Therapy
Humans
Hyperthermia, Induced
Infusions, Parenteral
Patient Care Planning
Patient Selection
Peritoneal Neoplasms
authors with profiles
Perry Shen MD
Edward A. Levine MD